CME Group Inc. (CME) Shares Sold by UMB Bank N A MO
UMB Bank N A MO reduced its stake in CME Group Inc. (NASDAQ:CME) by 10.1% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 195,301 shares of the financial services provider’s stock after selling 21,874 shares during the period. UMB Bank N A MO’s holdings in CME Group were worth $24,460,000 at the end of the most recent quarter.
A number of other large investors have also added to or reduced their stakes in the company. BlackRock Inc. boosted its position in shares of CME Group by 2,172.6% in the first quarter. BlackRock Inc. now owns 27,265,611 shares of the financial services provider’s stock valued at $3,239,152,000 after buying an additional 26,065,883 shares during the last quarter. Edgewood Management LLC boosted its position in CME Group by 26.4% in the first quarter. Edgewood Management LLC now owns 7,228,349 shares of the financial services provider’s stock worth $858,728,000 after buying an additional 1,511,753 shares during the last quarter. APG Asset Management N.V. boosted its position in CME Group by 335.2% in the first quarter. APG Asset Management N.V. now owns 1,899,723 shares of the financial services provider’s stock worth $225,687,000 after buying an additional 1,463,198 shares during the last quarter. Vanguard Group Inc. boosted its position in CME Group by 3.8% in the first quarter. Vanguard Group Inc. now owns 22,232,434 shares of the financial services provider’s stock worth $2,641,214,000 after buying an additional 806,282 shares during the last quarter. Finally, Wells Fargo & Company MN boosted its position in CME Group by 25.5% in the first quarter. Wells Fargo & Company MN now owns 3,490,351 shares of the financial services provider’s stock worth $414,653,000 after buying an additional 709,012 shares during the last quarter. Institutional investors own 83.29% of the company’s stock.
CME Group Inc. (NASDAQ CME) opened at 123.26 on Friday. The firm has a market capitalization of $41.90 billion, a price-to-earnings ratio of 25.16 and a beta of 0.73. CME Group Inc. has a one year low of $98.95 and a one year high of $127.96. The stock has a 50 day moving average price of $123.41 and a 200-day moving average price of $120.96.
CME Group (NASDAQ:CME) last posted its earnings results on Tuesday, August 1st. The financial services provider reported $1.23 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $1.20 by $0.03. CME Group had a return on equity of 7.61% and a net margin of 46.05%. The business had revenue of $925 million during the quarter, compared to the consensus estimate of $931.05 million. During the same period in the previous year, the business earned $1.14 EPS. The business’s quarterly revenue was up 2.1% on a year-over-year basis. On average, analysts predict that CME Group Inc. will post $4.81 earnings per share for the current fiscal year.
The company also recently announced a quarterly dividend, which will be paid on Monday, September 25th. Stockholders of record on Friday, September 8th will be issued a $0.66 dividend. This represents a $2.64 annualized dividend and a dividend yield of 2.14%. The ex-dividend date is Thursday, September 7th. CME Group’s payout ratio is currently 53.99%.
Several analysts recently issued reports on CME shares. UBS AG reissued a “buy” rating and set a $134.00 target price (down previously from $136.00) on shares of CME Group in a research note on Monday, June 5th. BidaskClub raised CME Group from a “sell” rating to a “hold” rating in a research note on Thursday, August 3rd. Royal Bank Of Canada set a $135.00 target price on CME Group and gave the company a “buy” rating in a research report on Tuesday, August 1st. Jefferies Group LLC reissued a “buy” rating and set a $128.00 target price on shares of CME Group in a research report on Monday, July 10th. Finally, Citigroup Inc. assumed coverage on CME Group in a research report on Wednesday, July 12th. They set a “buy” rating and a $140.00 target price on the stock. One investment analyst has rated the stock with a sell rating, three have issued a hold rating and five have assigned a buy rating to the company. The company currently has a consensus rating of “Hold” and an average price target of $131.63.
In related news, Director Ronald A. Pankau sold 300 shares of the business’s stock in a transaction dated Thursday, August 3rd. The stock was sold at an average price of $124.78, for a total value of $37,434.00. Following the transaction, the director now owns 4,009 shares in the company, valued at approximately $500,243.02. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Martin J. Gepsman sold 200 shares of the business’s stock in a transaction dated Wednesday, August 9th. The shares were sold at an average price of $126.14, for a total value of $25,228.00. Following the completion of the transaction, the director now owns 43,311 shares in the company, valued at approximately $5,463,249.54. The disclosure for this sale can be found here. Insiders sold a total of 91,085 shares of company stock valued at $11,242,896 over the last three months. Company insiders own 0.61% of the company’s stock.
CME Group Company Profile
CME Group Inc, through its exchanges, provides products across all asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products and metals. The Company’s segment primarily consists of the Chicago Mercantile Exchange Inc (CME), Board of Trade of the City of Chicago, Inc (CBOT), New York Mercantile Exchange, Inc (NYMEX) and Commodity Exchange, Inc (COMEX) exchanges.
Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CME).
Receive News & Ratings for CME Group Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.